Bumper Offer - Urjas oil Just @ Rs. 1 X
Vomiford MD Tablet, a prescription drug, is manufactured in various forms such as Tablet. Nausea and Vomiting are some of its major therapeutic uses.
The right dosage of Vomiford MD Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Vomiford MD Tablet as well, which are listed below. Such side effects of Vomiford MD Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Vomiford MD Tablet's effect is Safe during pregnancy and Mild for lactating mothers. In addition, Vomiford MD Tablet's effects on the liver, heart and kidney are discussed below in the Vomiford MD Tablet related warnings section.
Individuals suffering from medical conditions like Heart Disease, Calcium Deficiency, Potassium Deficiency must refrain from the use of Vomiford MD Tablet since this can cause severe adverse effects. Other contraindications of Vomiford MD Tablet have been discussed in the sections ahead.
Drug interactions for Vomiford MD Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Vomiford MD Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Vomiford MD Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Vomiford MD Tablet is used -
Moderate
Mild
Is the use of Vomiford MD Tablet safe for pregnant women?
Pregnant women can take Vomiford safely.
Is the use of Vomiford MD Tablet safe during breastfeeding?
Side effects of Vomiford for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Vomiford MD Tablet on the Kidneys?
Vomiford is completely safe for kidneys.
What is the effect of Vomiford MD Tablet on the Liver?
There may be an adverse effect on the liver after taking Vomiford. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Vomiford MD Tablet on the Heart?
There may be an adverse effect on the heart after taking Vomiford. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Vomiford MD Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Vomiford MD Tablet unless your doctor advises you to do so -
Is this Vomiford MD Tablet habit forming or addictive?
Vomiford MD Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Vomiford MD Tablet can make you feel drowsy.
Is it safe?
Yes, but take Vomiford MD Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Vomiford MD Tablet is not used to treat mental disorders.
Interaction between Food and Vomiford MD Tablet
Taking Vomiford MD Tablet with food does not harm your health.
Interaction between Alcohol and Vomiford MD Tablet
Taking alcohol with Vomiford MD Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)